Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

Onassis Holdings Enters the Rejuvenation Therapy Race with Innovative Epigenetic Programming

(PRNewsfoto/Onassis Holdings Corp)

News provided by

Onassis Holdings Corp

03 May, 2023, 22:18 IDT

Share this article

Share toX

Share this article

Share toX

Exclusive Partnership with a Leading Israeli University Accelerates Age-Defying Research

Plans for Reg A+ Registration to Raise Up to $75 Million for Expansion

NEW YORK, May 3, 2023 /PRNewswire/ -- Onassis Holdings Corp (OTC: ONSS), a wellness-focused holding company, is excited to announce its entry into the rejuvenation therapy market with a groundbreaking epigenetic programming technology. Through an exclusive perpetual license agreement with a leading Israeli university, Onassis Holdings will have the right to develop, manufacture, market, distribute, and sell products utilizing this cutting-edge technology worldwide.

Feel 30 at 60: Turning Back the Epigenetic Clock

Years of dedicated research have led to the development of a state-of-the-art epigenetic editing technique. This innovative technology has the potential to reset the epigenetic clock in aged cells, reversing the loss of functional activity and restoring cells to their youthful state.

Epigenetic editing uses specialized proteins to make targeted changes to the chemical marks on DNA that influence gene activity. These marks accumulate as cells age, leading to the loss of function and the development of age-related diseases. By selectively modifying these marks, epigenetic editing can rejuvenate cells, effectively turning back the clock on aging and improving overall health.

Science:

Targeting Age-Related Diseases with Pioneering Epigenetic Programming

Epigenetic programming technology not only reverses the aging process but also offers the potential to treat and cure specific age-related diseases, such as Alzheimer's, Parkinson's, age-related macular degeneration, and more. By rejuvenating aged cells and restoring their proper function, the technology addresses the root cause of these conditions, opening the door to healthier, longer lives for those affected.

For more information about Onassis: 
Onassis Holdings Corp. 
+1-516-620-6794 
[email protected] 
www.onassis-holdings.com

Logo: https://mma.prnewswire.com/media/2069172/Onassis_Holdings_Corp_Logo.jpg

SOURCE Onassis Holdings Corp

Modal title

Also from this source

Onassis Holdings Appoints Esq. Paz Itzhaki-Weinberger to Advisory Board to Oversee International Law and Trade

Onassis Holdings Appoints Esq. Paz Itzhaki-Weinberger to Advisory Board to Oversee International Law and Trade

Onassis Holding Corp (OTC: ONSS) a US public company pioneering cellular rejuvenation and longevity biotechnology, is pleased to announce the...

Onassis Holdings Retained Investment Bank Dalmore Group to Launch up to $75 Million Regulation A+ Offering (Mini IPO)

Onassis Holdings Retained Investment Bank Dalmore Group to Launch up to $75 Million Regulation A+ Offering (Mini IPO)

Onassis Holding Corp (OTC: ONSS), a biotech focused holding company, announced the launch of a Regulation A+ financing round. This follows an...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.